Centogene NV
No trades
No trades
Compare with Centogene NV
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Details
Sector
Industry
CEO
David Jiménez
Website
Headquarters
Rostock
Founded
2006
IPO date
Nov 7, 2019
ISIN
NL0014040206
FIGI
BBG00QT69C83
Identifiers
ISIN NL0014040206
Centogene NV is a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. It operates through the following segments: Pharmaceutical, Diagnostics, and Corporate. The Pharmaceutical segment provides solutions to pharmaceutical partners, including target discovery, early patient recruitment and identification, epidemiological insights, and biomarker discovery. The Diagnostics segment offers genetic sequencing and diagnostics services to clients, who are typically physicians, laboratories, or hospitals, either directly or through distributors. The Other segment covers COVID-19 testing services to clients. The company was founded by Arndt Rolf and Christoph Ehlers in 2006 and is headquartered in Rostock, Denmark.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
Depending on the exchange, the stock ticker may vary. For instance, on MUN exchange Centogene NV stocks are traded under the ticker 39K.
Yes, you can track Centogene NV financials in yearly and quarterly reports right on TradingView.
Centogene NV is going to release the next earnings report on Sep 11, 2026. Keep track of upcoming events with our Earnings Calendar.
Like other stocks, 39K shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Centogene NV stock right from TradingView charts — choose your broker and connect to your account.